FDA Approved: DILTIAZEM HYDROCHLORIDE — Supplemental Application (ScieGen Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for diltiazem hydrochloride from ScieGen Pharmaceuticals, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Angina Pectoris
• Atrial Fibrillation
• Atrial Flutter
• Hypertension
• Supraventricular Tachycardia
• Vasospastic Angina

Drugs mentioned

• Diltiazem hydrochloride (Diltiazem hydrochloride)

Snippet

SUPPL AP for DILTIAZEM HYDROCHLORIDE (DILTIAZEM HYDROCHLORIDE)